An official website of the United States government
Home
Multiple Primaries Calculator
The Multiple Primaries Calculator was designed to be used with the coding manual. Follow the rules and workflow in the manual prior to using the calculator. Use the Multiple Primaries Calculator when the rules instruct you to do so. If you are working with cases diagnosed before 2010 use the ICD-O-3 Hematopoietic Primaries Table (PDF) instead. This calculator should only be used for cases where at least one of the diagnoses is from 2010 or forward.
110 neoplasms
match
any term
21 neoplasms match
all terms
Show
Entries
| Relevance | ICD-O-3 Morphology | ▲ Name | Alternate Names |
|---|---|---|---|
|
25.71428571428571
|
9714/3 | ALK-positive anaplastic large cell lymphoma (ALCL) |
ALK positive anaplastic large cell lymphoma, common
ALK positive anaplastic large cell lymphoma, composite ALK positive anaplastic large cell lymphoma, Hodgkin like ALK positive anaplastic large cell lymphoma, lymphohistiocytic |
|
2.857142857142857
|
9750/3 | ALK-positive histiocytosis | |
|
23.714285714285715
|
9737/3 | ALK-positive large B-cell lymphoma (ALK+ LBCL) | |
|
1.7142857142857144
|
9861/3 | Acute myeloid leukemia (AML), NOS |
Acute non-lymphocytic leukemia
|
|
24.285714285714285
|
9827/3 | Adult T-cell leukemia/lymphoma (ATLL) |
Lymphoma adult T-cell leukemia/lymphoma (Lymphoma ATLL)
Adult T-cell lymphoma Acute adult T-cell leukemia/lymphoma (Acute ATLL) Adult T-cell leukemia/lymphoma (HTLV-1 positive/associated) |
|
2.857142857142857
|
9948/3 | Aggressive NK-cell leukemia (ANKL) |
Aggressive NK-cell leukemia/lymphoma
|
|
38.0
|
9715/3 | Anaplastic large cell lymphoma, ALK-negative (ALK-ALCL) |
ALK-negative anaplastic large cell lymphoma
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) Seroma-associated anaplastic large cell lymphoma |
|
7.142857142857142
|
None | Autoimmune lymphoproliferative syndrome (ALP) | |
|
27.142857142857142
|
9813/3 | B lymphoblastic leukemia/lymphoma [B-ALL/LBL] with KMT2A rearrangement |
B lymphoblastic leukemia/lymphoma with t(v;11q23); MLL-rearranged
|
|
27.142857142857142
|
9812/3 | B-lymphoblastic leukemia/lymphoma [B-ALL/LBL] with BCR::ABL1 fusion |
B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1 (B ALL with BCR ABL1)
|
|
26.571428571428573
|
9819/3 | B-lymphoblastic leukemia/lymphoma [B-ALL/LBL] with BCR::ABL1 like features (BCR::ABL1-like B-ALL/LBL) |
B-lymphoblastic leukemia/lymphoma, BCR-ABL1-like
|
|
27.142857142857142
|
9814/3 | B-lymphoblastic leukemia/lymphoma [B-ALL/LBL] with ETV6::RUNX1 fusion |
B-lymphoblstic leukemia/lymphoma with ETV6::RUNX1-like features (B-ALL, ETV6::RUNX1-like)
B lymphoblastic leukemia/lymphoma with t(12;21)(p13;q22); TEL-AML1(ETV6-RUNX1) |
|
27.142857142857142
|
9817/3 | B-lymphoblastic leukemia/lymphoma [B-ALL/LBL] with IGH::IL3 fusion |
B-lymphoblastic leukemia/lymphoma with t(5;14)(q31;q32); IL3-IGH
|
|
27.142857142857142
|
9818/3 | B-lymphoblastic leukemia/lymphoma [B-ALL/LBL] with TCF3::PBX1 |
B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)
B-lymphoblastic leukemia/lymphoma with TCF3::HLF |
|
27.142857142857142
|
9816/3 | B-lymphoblastic leukemia/lymphoma [B-ALL/LBL] with hypodiploidy (Hypodiploid B-ALL/LBL) |
B lymphoblastic leukemia/lymphoma, near-haploidy (B-ALL/LBL with near-haploidy)
B lymphoblastic leukemia/lymphoma, low hypodiploid (B-ALL/LBL with low hypodiploidy) B lymphoblastic leukemia/lymphoma, high-hypodiploid (B-ALL/LBL with high hypodiploidy) |
|
39.714285714285715
|
9811/3 | B-lymphoblastic leukemia/lymphoma [B-ALL/LBL], NOS |
B-lymphoblastic leukemia/lymphoma with DUX4 rearrangement
B-lymphoblastic leukemia/lymphoma, iAMP21 B-lymphoblastic leukemia/lymphoma with MEF2D rearrangement B-lymphoblastic leukemia/lymphoma with MYC rearrangement |
|
27.142857142857142
|
9815/3 | B-lymphoblastic leukemia/lymphoma with high hyperdiploidy (B-ALL/LBL with high hyperdiploidy) |
B-lymphoblastic leukemia/lymphoma with hyperdiploidy
|
|
16.0
|
9727/3 | Blastic plasmacytoid dendritic cell neoplasm (BPDC) |
Blastic NK-cell lymphoma [OBS]
Malignant lymphoma, convoluted cell [OBS] (see 9811/3 for 2010+) Malignant lymphoma, lymphoblastic, NOS (see 9811/3 for 2010+) |
|
1.1428571428571428
|
None | Bloom syndrome | |
|
7.428571428571429
|
9826/3 | Burkitt cell leukemia (see 9687/3 for 2021+) obsolete |
Acute lymphocytic leukemia FAB L3 [OBS] (see 9687/3 for 2021+)
|
|
33.714285714285715
|
9687/3 | Burkitt lymphoma (BL), (NOS) |
Acute lymphocytic leukemia mature FAB L3 [OBS] (see 9826/3 prior to 2021)
Burkitt-like lymphoma, NOS Burkitt-like lymphoma with 11q aberration EBV-associated Burkitt lymphoma |
|
0.5714285714285714
|
None | Castleman disease | |
|
4.571428571428571
|
9964/3 | Chronic eosinophilic leukemia (CEL) |
Lymphocytic variant hypereosinophilic syndrome (L-HES)
|
|
58.857142857142854
|
9823/3 | Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) |
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma
Malignant lymphoma, lymphocytic, diffuse, NOS (see 9670/3 prior to 2010) Malignant lymphoma, lymphocytic, NOS [OBS] (see 9670/3 prior to 2010) Malignant lymphoma, lymphocytic, well differentiated, diffuse [OBS] (see 9670/3 prior to 2010) |
|
24.571428571428573
|
9650/3 | Classic Hodgkin lymphoma (CHL), NOS |
Classical Hodgkin lymphoma post-transplant lymphoproliferative disease (PTLD)
Hodgkin lymphoma (HL), NOS Malignant lymphoma, Hodgkin |
